ConductScience.org, home

Gene · 3206

NIH grants1,328

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleHOXA10 papersNewest fiscal year
R35CA197561Molecular Pathogenesis of Acute Myeloid Leukemia22025
R37AI039394Biochemical Mechanism of HIV DNA Integration22025
T32AG000181Training in the Epidemiology of Aging22025
T32AR007175UCSF Dermatology Training Grant22025
T32CA009056Tumor Cell Biology Training Program22025
T32CA009515Training in cancer biology and transplantation22025
T32CA009594Multi-Disciplinary Training Grant in Cancer Research22025
T32DK007169NW University Program in Endo Diabetes and Hormone Action22025
T32ES007091Training in Environmental Toxicology of Human Disease22025
T32HL007088Pre-and Postgraduate Training in Molecular Hematology22025
T32HL007574Pathophysiology of Human Blood Cells22025
U10CA180899Children's Oncology Group Statistics and Data Center22025
U54MD007602Center for Translational Research in Health Disparities22025
ZIAES071006Epigenetic and Transcriptional Functions of Nuclear Receptors and Chromatin Remodeling Proteins in Stem and Cancer Cells22025
ZIAES103311Environmental Signaling in Reproduction and Pregnancy22025
ZIAHD002400The Role Of Subclinical Infection And Cytokines In Preterm Parturition22025
ZIAHG000030Mechanistic and translational studies of CBF leukemia22025
ZIEHD008737Reproductive Endocrinology and Infertility Clinical Training Program22025
DP5OD033357Long-read DNA and RNA sequencing to identify disease-causing genetic variation and streamline testing12025
I01BX004635Molecular mechanisms of drug resistance and disease progression in acute myeloid leukemia.12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3206/grants?page=3